QUALITY OF LIFE IN THE PHASE III CeTeG/NOA-09 TRIAL RANDOMIZING CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA

Weller, Johannes and Tzaridis, Theophilos and Steinbach, Joachim and Schlegel, Uwe and Hau, Peter and Krex, Dietmar and Grauer, Oliver and Goldbrunner, Roland and Baehr, Oliver and Uhl, Martin and Seidel, Clemens and Tabatabai, Ghazaleh and Bullinger, Lars and Galldiks, Norbert and Schaub, Christina and Stummer, Walter and Simon, Matthias and Fimmers, Rolf and Matthias, Schmid and Coch, Christoph and Glas, Martin and Herrlinger, Ulrich and Schaefer, Niklas (2018) QUALITY OF LIFE IN THE PHASE III CeTeG/NOA-09 TRIAL RANDOMIZING CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA. NEURO-ONCOLOGY, 20 (Suppl6). vi218-vi219. ISSN 1522-8517, 1523-5866

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Neurologie
Medicine > Zentren des Universitätsklinikums Regensburg > Zentrum für Hirntumore (ZHT)
Depositing User: Petra Gürster
Date Deposited: 17 Jul 2020 09:43
Last Modified: 17 Jul 2020 09:43
URI: https://pred.uni-regensburg.de/id/eprint/13565

Actions (login required)

View Item View Item